IINX yields 200000000.00% · PFE yields 6.20%● Live data
📍 IINX pulled ahead of the other in Year 1
Combined, IINX + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of IINX + PFE for your $10,000?
Ionix Technology, Inc., together with its subsidiaries, engages in the research and development, manufacture, and marketing of liquid crystal materials, displays, and modules in the United States, Hong Kong, and the People's Republic of China. It operates through three segments: Smart Energy, Photoelectric Display, and Service Contracts. The company provides electronic equipment, such as power banks for iphone, ipad, mp3/mp4 players, PSP gaming systems, and cameras; and liquid crystal module and liquid crystal display screens for video capable baby monitors, tablets and cell phones, and televisions or computer monitors. It distributes its products to distributors and retailers. The company was formerly known as Cambridge Projects Inc. and changed its name to Ionix Technology, Inc. in February 2016. Ionix Technology, Inc. was incorporated in 2011 and is based in Dalian, China. Ionix Technology, Inc. is a subsidiary of Shining Glory Investments Limited.
Full IINX Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.